Autor:	DavidS. Leake, NigelG. Stephens, IanS. Young, StephenR. Vallely, GeoffreyP. Walsh, ElizabethR. Trimble, Farzin Fath-Ordoubadi, DerekM. Yellon, JohnA. Purvis, SusieD. Morris, Kofo Ogunyankin, A.A.Jennifer Adgey
Rok vydání:	1996
Předmět:	medicine.medical_specialty Framingham Risk Score business.industry Vitamin E medicine.medical_treatment General Medicine Coronary disease medicine.disease Coronary heart disease Internal medicine medicine Cardiology Myocardial infarction business
Zdroj:	The Lancet. 347:1689-1691
ISSN:	0140-6736
DOI:	10.1016/s0140-6736(96)91517-2
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::04c2e35dd1e67aec601bd045997b5022 https://doi.org/10.1016/s0140-6736(96)91517-2 Zobrazit plný text záznamu